Tapewire

Nasdaq · USD

DTIL

PRECISION BIOSCIENCES INC

Export transactions ↓
Tapewire entity
6284
SEC CIK
0001357874
Parsed reports
268

Last 12 months

Inside the activity.

6 purchase rows · 11 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202503
Dec 202530
Jan 202604
Feb 202604
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202630
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 29, 2024 Filed May 3, 2024 22:32 UTC
SMITH J. JEFFERSONChief Research Officer
GrantCommon Stock 1,006 $12.42 $12,494.52
Disclosure

SEC source: 0000950170-24-053114 · ownership.xml · nonDerivative · entry 1

SMITH J. JEFFERSON · CIK 0001770169 · Chief Research Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 67,248

Read SEC document
January 23, 2024 Filed Jan 24, 2024 00:11 UTC
SMITH J. JEFFERSONChief Research Officer
SaleCommon Stock 28,000 $0.37 $10,360.00
Disclosure

SEC source: 0001209191-24-002113 · doc4.xml · nonDerivative · entry 2

SMITH J. JEFFERSON · CIK 0001770169 · Chief Research Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,987,269

F3 · kind: The transaction was a sell-to-cover, with shares sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The reporting person did not sell or otherwise dispose of shares reported on this Form 4 for any reason other than to cover required taxes and fees.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.35495 to $0.37790. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote.

Read SEC document
January 22, 2024 Filed Jan 23, 2024 19:15 UTC
Scimeca DarioGeneral Counsel and Secretary
SaleCommon Stock 21,287 $0.36 $7,663.32
Disclosure

SEC source: 0001209191-24-002117 · doc4.xml · nonDerivative · entry 2

Scimeca Dario · CIK 0001779581 · General Counsel and Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 151,028

F3 · kind: The sales were effected pursuant to a Rule 10b5-1 plan adopted on July 14, 2023. The transaction was a sell-to-cover, with shares only sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The Reporting Person did not sell or otherwise dispose of shares reported on this Form 4 for any reason other than to cover required taxes and fees.

Read SEC document
January 22, 2024 Filed Jan 24, 2024 00:17 UTC
Amoroso MichaelDirector · President and CEO
SaleCommon Stock 137,390 $0.36 $49,460.40
Disclosure

SEC source: 0001209191-24-002119 · doc4.xml · nonDerivative · entry 2

Amoroso Michael · CIK 0001830874 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 356,433

F3 · kind: The sales were effected pursuant to a Rule 10b5-1 plan adopted on March 24, 2022. The transaction was a sell-to-cover, with shares only sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The Reporting Person did not sell or otherwise dispose of shares reported on this Form 4 for any reason other than to cover required taxes and fees.

Read SEC document
January 22, 2024 Filed Jan 24, 2024 00:13 UTC
List AlanChief Medical Officer
SaleCommon Stock 21,526 $0.36 $7,749.36
Disclosure

SEC source: 0001209191-24-002115 · doc4.xml · nonDerivative · entry 2

List Alan · CIK 0001858530 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 94,982

F3 · kind: The sales were effected pursuant to a Rule 10b5-1 plan adopted on September 10, 2021. The transaction was a sell-to-cover, with shares only sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The Reporting Person did not sell or otherwise dispose of shares reported on this Form 4 for any reason other than to cover required taxes and fees.

Read SEC document
January 20, 2024 Filed Jan 23, 2024 19:15 UTC
Scimeca DarioGeneral Counsel and Secretary
Exercise / conversionRestricted Stock Units · Derivative 59,345 $0.00 $0.00
Disclosure

SEC source: 0001209191-24-002117 · doc4.xml · derivative · entry 3

Scimeca Dario · CIK 0001779581 · General Counsel and Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 118,655

Underlying: Common Stock · 59,345 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such share.

F4 · derivative.exercise_date: On January 20, 2023 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on January 20, 2024, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

F4 · derivative.expiration_date: On January 20, 2023 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on January 20, 2024, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

Read SEC document
January 20, 2024 Filed Jan 23, 2024 19:15 UTC
Scimeca DarioGeneral Counsel and Secretary
Exercise / conversionCommon Stock 59,345 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-24-002117 · doc4.xml · nonDerivative · entry 1

Scimeca Dario · CIK 0001779581 · General Counsel and Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 172,315

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents the partial vesting and settlement of Restricted Stock Units ("RSUs") on January 20, 2024.

F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such share.

Read SEC document
January 20, 2024 Filed Jan 24, 2024 00:19 UTC
Kelly John AlexanderChief Financial Officer
Exercise / conversionRestricted Stock Units · Derivative 116,690 $0.00 $0.00
Disclosure

SEC source: 0001209191-24-002121 · doc4.xml · derivative · entry 2

Kelly John Alexander · CIK 0001590030 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 233,310

Underlying: Common Stock · 116,690 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such share.

F3 · derivative.exercise_date: On January 20, 2023 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on January 20, 2024, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

F3 · derivative.expiration_date: On January 20, 2023 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on January 20, 2024, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

Read SEC document
January 20, 2024 Filed Jan 24, 2024 00:19 UTC
Kelly John AlexanderChief Financial Officer
Exercise / conversionCommon Stock 116,690 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-24-002121 · doc4.xml · nonDerivative · entry 1

Kelly John Alexander · CIK 0001590030 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 614,169

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents the partial vesting and settlement of Restricted Stock Units ("RSUs") on January 20, 2024.

F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such share.

Read SEC document
January 20, 2024 Filed Jan 24, 2024 00:17 UTC
Amoroso MichaelDirector · President and CEO
Exercise / conversionRestricted Stock Units · Derivative 266,720 $0.00 $0.00
Disclosure

SEC source: 0001209191-24-002119 · doc4.xml · derivative · entry 3

Amoroso Michael · CIK 0001830874 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 533,280

Underlying: Common Stock · 266,720 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such share.

F4 · derivative.exercise_date: On January 20, 2023 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on January 20, 2024, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

F4 · derivative.expiration_date: On January 20, 2023 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on January 20, 2024, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

Read SEC document
January 20, 2024 Filed Jan 24, 2024 00:17 UTC
Amoroso MichaelDirector · President and CEO
Exercise / conversionCommon Stock 266,720 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-24-002119 · doc4.xml · nonDerivative · entry 1

Amoroso Michael · CIK 0001830874 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 493,823

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents the partial vesting and settlement of Restricted Stock Units ("RSUs") on January 20, 2024.

F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such share.

Read SEC document
January 20, 2024 Filed Jan 24, 2024 00:13 UTC
List AlanChief Medical Officer
Exercise / conversionRestricted Stock Units · Derivative 60,012 $0.00 $0.00
Disclosure

SEC source: 0001209191-24-002115 · doc4.xml · derivative · entry 3

List Alan · CIK 0001858530 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 119,988

Underlying: Common Stock · 60,012 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such share.

F4 · derivative.exercise_date: On January 20, 2023 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on January 20, 2024, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

F4 · derivative.expiration_date: On January 20, 2023 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on January 20, 2024, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

Read SEC document
January 20, 2024 Filed Jan 24, 2024 00:13 UTC
List AlanChief Medical Officer
Exercise / conversionCommon Stock 60,012 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-24-002115 · doc4.xml · nonDerivative · entry 1

List Alan · CIK 0001858530 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 116,508

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents the partial vesting and settlement of Restricted Stock Units ("RSUs") on January 20, 2024.

F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such share.

Read SEC document
January 20, 2024 Filed Jan 24, 2024 00:11 UTC
SMITH J. JEFFERSONChief Research Officer
Exercise / conversionRestricted Stock Units · Derivative 75,015 $0.00 $0.00
Disclosure

SEC source: 0001209191-24-002113 · doc4.xml · derivative · entry 4

SMITH J. JEFFERSON · CIK 0001770169 · Chief Research Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 149,985

Underlying: Common Stock · 75,015 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such share.

F5 · derivative.exercise_date: On January 20, 2023 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on January 20, 2024, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

F5 · derivative.expiration_date: On January 20, 2023 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on January 20, 2024, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

Read SEC document
January 20, 2024 Filed Jan 24, 2024 00:11 UTC
SMITH J. JEFFERSONChief Research Officer
Exercise / conversionCommon Stock 75,015 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-24-002113 · doc4.xml · nonDerivative · entry 1

SMITH J. JEFFERSON · CIK 0001770169 · Chief Research Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,015,269

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents the partial vesting and settlement of Restricted Stock Units ("RSUs") on January 20, 2024.

F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such share.

Read SEC document
November 03, 2023 Filed Nov 6, 2023 17:09 UTC
Scimeca DarioGeneral Counsel and Secretary
SaleCommon Stock 16,023 $0.40 $6,409.20
Disclosure

SEC source: 0001209191-23-054552 · doc4.xml · nonDerivative · entry 2

Scimeca Dario · CIK 0001779581 · General Counsel and Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 112,970

F3 · kind: The sales were effected pursuant to a Rule 10b5-1 plan adopted on July 14, 2023. The transaction was a sell-to-cover, with shares sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs.

F3 · shares: The sales were effected pursuant to a Rule 10b5-1 plan adopted on July 14, 2023. The transaction was a sell-to-cover, with shares sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs.

Read SEC document
November 03, 2023 Filed Nov 6, 2023 22:07 UTC
Amoroso MichaelDirector · President and CEO
SaleCommon Stock 125,025 $0.40 $50,010.00
Disclosure

SEC source: 0001209191-23-054549 · doc4.xml · nonDerivative · entry 2

Amoroso Michael · CIK 0001830874 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 227,103

F3 · kind: The sales were effected pursuant to a Rule 10b5-1 plan adopted on March 24, 2022. The transaction was a sell-to-cover, with shares sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs.

Read SEC document
November 02, 2023 Filed Nov 6, 2023 17:09 UTC
Scimeca DarioGeneral Counsel and Secretary
Exercise / conversionRestricted Stock Units · Derivative 55,077 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-054552 · doc4.xml · derivative · entry 3

Scimeca Dario · CIK 0001779581 · General Counsel and Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 110,123

Underlying: Common Stock · 55,077 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such share.

F4 · derivative.exercise_date: On November 2, 2022 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on November 2, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

F4 · derivative.expiration_date: On November 2, 2022 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on November 2, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

Read SEC document
November 02, 2023 Filed Nov 6, 2023 17:09 UTC
Scimeca DarioGeneral Counsel and Secretary
Exercise / conversionCommon Stock 55,077 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-054552 · doc4.xml · nonDerivative · entry 1

Scimeca Dario · CIK 0001779581 · General Counsel and Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 128,993

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents the partial vesting and settlement of Restricted Stock Units ("RSUs") on November 2, 2023.

F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such share.

Read SEC document
November 02, 2023 Filed Nov 6, 2023 22:04 UTC
Kelly John AlexanderChief Financial Officer
Exercise / conversionRestricted Stock Units · Derivative 108,188 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-054546 · doc4.xml · derivative · entry 2

Kelly John Alexander · CIK 0001590030 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 216,312

Underlying: Common Stock · 108,188 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such share.

F3 · derivative.exercise_date: On November 2, 2022 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on November 2, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

F3 · derivative.expiration_date: On November 2, 2022 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on November 2, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

Read SEC document
November 02, 2023 Filed Nov 6, 2023 22:04 UTC
Kelly John AlexanderChief Financial Officer
Exercise / conversionCommon Stock 108,188 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-054546 · doc4.xml · nonDerivative · entry 1

Kelly John Alexander · CIK 0001590030 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 497,479

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents the partial vesting and settlement of Restricted Stock Units ("RSUs") on November 2, 2023.

F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such share.

Read SEC document
November 02, 2023 Filed Nov 6, 2023 22:07 UTC
Amoroso MichaelDirector · President and CEO
Exercise / conversionRestricted Stock Units · Derivative 283,390 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-054549 · doc4.xml · derivative · entry 3

Amoroso Michael · CIK 0001830874 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 566,610

Underlying: Common Stock · 283,390 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such share.

F4 · derivative.exercise_date: On November 2, 2022 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on November 2, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

F4 · derivative.expiration_date: On November 2, 2022 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on November 2, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

Read SEC document
November 02, 2023 Filed Nov 6, 2023 22:07 UTC
Amoroso MichaelDirector · President and CEO
Exercise / conversionCommon Stock 283,390 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-054549 · doc4.xml · nonDerivative · entry 1

Amoroso Michael · CIK 0001830874 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 352,128

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents the partial vesting and settlement of Restricted Stock Units ("RSUs") on November 2, 2023.

F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such share.

Read SEC document
August 31, 2023 Filed Sep 5, 2023 16:16 UTC
Scimeca DarioGeneral Counsel and Secretary
GrantCommon Stock 5,443 $0.39 $2,122.77
Disclosure

SEC source: 0001209191-23-048150 · doc4.xml · nonDerivative · entry 1

Scimeca Dario · CIK 0001779581 · General Counsel and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 73,916

F1 · kind: These shares were acquired under the Issuer's 2019 Employee Stock Purchase Plan subsequent to the Reporting Person's Form 4 filed on June 9, 2023.

Read SEC document
August 31, 2023 Filed Sep 5, 2023 20:15 UTC
SMITH J. JEFFERSONChief Research Officer
GrantCommon Stock 5,175 $0.39 $2,018.25
Disclosure

SEC source: 0001209191-23-048145 · doc4.xml · nonDerivative · entry 1

SMITH J. JEFFERSON · CIK 0001770169 · Chief Research Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,940,254

F1 · kind: These shares were acquired under the Issuer's 2019 Employee Stock Purchase Plan subsequent to the Reporting Person's Form 4 filed on June 9, 2023.

Read SEC document
August 31, 2023 Filed Sep 5, 2023 20:15 UTC
Kelly John AlexanderChief Financial Officer
GrantCommon Stock 5,951 $0.39 $2,320.89
Disclosure

SEC source: 0001209191-23-048144 · doc4.xml · nonDerivative · entry 1

Kelly John Alexander · CIK 0001590030 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 389,291

F1 · kind: These shares were acquired under the Issuer's 2019 Employee Stock Purchase Plan subsequent to the Reporting Person's Form 4 filed on August 22, 2023.

Read SEC document
August 18, 2023 Filed Aug 22, 2023 20:10 UTC
Kelly John AlexanderChief Financial Officer
GrantCommon Stock 90,000 $0.48 $43,200.00
Disclosure

SEC source: 0001209191-23-046874 · doc4.xml · nonDerivative · entry 1

Kelly John Alexander · CIK 0001590030 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 383,340

F1 · price: The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $0.47 to $0.485. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote.

Read SEC document
August 18, 2023 Filed Oct 27, 2023 20:55 UTC Amendment
Kelly John AlexanderChief Financial Officer
PurchaseCommon Stock 90,000 $0.48 $43,200.00
Disclosure

SEC source: 0001209191-23-053784 · doc4a.xml · nonDerivative · entry 1

Kelly John Alexander · CIK 0001590030 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 383,340

F1 · kind: This amendment is being filed to correct the Transaction Code (as set forth in Box 3). The Form 4, as originally filed, inadvertently reported the Transaction Code as "A."

F2 · price: The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $0.47 to $0.485. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote.

Read SEC document
June 08, 2023 Filed Jun 9, 2023 16:15 UTC
Scimeca DarioGeneral Counsel and Secretary
SaleCommon Stock 13,361 $0.75 $10,020.75
Disclosure

SEC source: 0001209191-23-035789 · doc4.xml · nonDerivative · entry 3

Scimeca Dario · CIK 0001779581 · General Counsel and Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 68,473

F3 · kind: The sales were effected pursuant to a Rule 10b5-1 plan. The transaction was a sell-to-cover, with shares sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs.

Read SEC document
June 07, 2023 Filed Jun 9, 2023 16:15 UTC
Scimeca DarioGeneral Counsel and Secretary
Exercise / conversionRestricted Stock Units · Derivative 9,044 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-035789 · doc4.xml · derivative · entry 5

Scimeca Dario · CIK 0001779581 · General Counsel and Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 9,045

Underlying: Common Stock · 9,044 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such share.

F5 · derivative.exercise_date: On June 7, 2021 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on June 7, 2022, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

F5 · derivative.expiration_date: On June 7, 2021 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on June 7, 2022, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

Read SEC document
June 07, 2023 Filed Jun 9, 2023 16:15 UTC
Scimeca DarioGeneral Counsel and Secretary
Exercise / conversionRestricted Stock Units · Derivative 22,727 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-035789 · doc4.xml · derivative · entry 4

Scimeca Dario · CIK 0001779581 · General Counsel and Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 22,727 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such share.

F4 · derivative.exercise_date: On June 7, 2021 the Reporting Person was granted RSUs, which vest in two equal annual installments beginning on June 7, 2022, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

F4 · derivative.expiration_date: On June 7, 2021 the Reporting Person was granted RSUs, which vest in two equal annual installments beginning on June 7, 2022, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

Read SEC document
June 07, 2023 Filed Jun 9, 2023 16:15 UTC
Scimeca DarioGeneral Counsel and Secretary
Exercise / conversionCommon Stock 9,044 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-035789 · doc4.xml · nonDerivative · entry 2

Scimeca Dario · CIK 0001779581 · General Counsel and Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 81,834

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents the partial vesting and settlement of Restricted Stock Units ("RSUs") on June 7, 2023.

F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such share.

Read SEC document
June 07, 2023 Filed Jun 9, 2023 16:15 UTC
Scimeca DarioGeneral Counsel and Secretary
Exercise / conversionCommon Stock 22,727 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-035789 · doc4.xml · nonDerivative · entry 1

Scimeca Dario · CIK 0001779581 · General Counsel and Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 72,790

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents the partial vesting and settlement of Restricted Stock Units ("RSUs") on June 7, 2023.

F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such share.

Read SEC document
June 07, 2023 Filed Jun 9, 2023 20:20 UTC
Barton ShaneVP & Corporate Controller
Exercise / conversionRestricted Stock Units · Derivative 6,060 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-035835 · doc4.xml · derivative · entry 2

Barton Shane · CIK 0001836297 · VP & Corporate Controller

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,060

Underlying: Common Stock · 6,060 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such share.

F4 · derivative.exercise_date: On June 7, 2021 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on June 7, 2022, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

F4 · derivative.expiration_date: On June 7, 2021 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on June 7, 2022, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

Read SEC document
June 07, 2023 Filed Jun 9, 2023 20:20 UTC
Barton ShaneVP & Corporate Controller
Exercise / conversionCommon Stock 6,060 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-035835 · doc4.xml · nonDerivative · entry 1

Barton Shane · CIK 0001836297 · VP & Corporate Controller

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,502

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents the partial vesting and settlement of Restricted Stock Units ("RSUs") on June 7, 2023.

F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such share.

F3 · balance_after: Amount includes 20 shares that were inadvertently omitted from the Form 4 filed on March 7, 2023 by the Reporting Person.

Read SEC document
June 07, 2023 Filed Jun 9, 2023 20:15 UTC
Kelly John AlexanderChief Financial Officer
Exercise / conversionRestricted Stock Units · Derivative 13,635 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-035792 · doc4.xml · derivative · entry 4

Kelly John Alexander · CIK 0001590030 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,635

Underlying: Common Stock · 13,635 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such share.

F4 · derivative.exercise_date: On June 7, 2021 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on June 7, 2022, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

F4 · derivative.expiration_date: On June 7, 2021 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on June 7, 2022, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

Read SEC document
June 07, 2023 Filed Jun 9, 2023 20:15 UTC
Kelly John AlexanderChief Financial Officer
Exercise / conversionRestricted Stock Units · Derivative 34,091 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-035792 · doc4.xml · derivative · entry 3

Kelly John Alexander · CIK 0001590030 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 34,091 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such share.

F3 · derivative.exercise_date: On June 7, 2021 the Reporting Person was granted RSUs, which vest in two substantially equal annual installments beginning on June 7, 2022, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

F3 · derivative.expiration_date: On June 7, 2021 the Reporting Person was granted RSUs, which vest in two substantially equal annual installments beginning on June 7, 2022, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

Read SEC document
June 07, 2023 Filed Jun 9, 2023 20:15 UTC
Kelly John AlexanderChief Financial Officer
Exercise / conversionCommon Stock 13,635 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-035792 · doc4.xml · nonDerivative · entry 2

Kelly John Alexander · CIK 0001590030 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 293,340

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents the partial vesting and settlement of Restricted Stock Units ("RSUs") on June 7, 2023.

F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such share.

Read SEC document
June 07, 2023 Filed Jun 9, 2023 20:15 UTC
Kelly John AlexanderChief Financial Officer
Exercise / conversionCommon Stock 34,091 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-035792 · doc4.xml · nonDerivative · entry 1

Kelly John Alexander · CIK 0001590030 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 279,705

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents the partial vesting and settlement of Restricted Stock Units ("RSUs") on June 7, 2023.

F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such share.

Read SEC document
June 07, 2023 Filed Jun 9, 2023 20:15 UTC
SMITH J. JEFFERSONChief Research Officer
Exercise / conversionRestricted Stock Units · Derivative 4,872 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-035790 · doc4.xml · derivative · entry 3

SMITH J. JEFFERSON · CIK 0001770169 · Chief Research Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,872

Underlying: Common Stock · 4,872 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such share.

F3 · derivative.exercise_date: On June 7, 2021 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on June 7, 2022, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

F3 · derivative.expiration_date: On June 7, 2021 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on June 7, 2022, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

Read SEC document
June 07, 2023 Filed Jun 9, 2023 20:15 UTC
SMITH J. JEFFERSONChief Research Officer
Exercise / conversionCommon Stock 4,872 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-035790 · doc4.xml · nonDerivative · entry 1

SMITH J. JEFFERSON · CIK 0001770169 · Chief Research Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,935,079

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents the partial vesting and settlement of Restricted Stock Units ("RSUs") on June 7, 2023.

F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such share.

Read SEC document
May 04, 2023 Filed May 8, 2023 20:15 UTC GrantRestricted Stock Units · Derivative 126,075 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-027927 · doc4.xml · derivative · entry 1

Frankel Stanley · CIK 0001855726 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 126,075

Underlying: Common Stock · 126,075 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such shares.

F2 · derivative.exercise_date: The RSUs vest on the earlier to occur of (i) May 4, 2024 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date.

F2 · derivative.expiration_date: The RSUs vest on the earlier to occur of (i) May 4, 2024 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date.

Read SEC document
May 04, 2023 Filed May 8, 2023 20:15 UTC GrantRestricted Stock Units · Derivative 126,075 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-027922 · doc4.xml · derivative · entry 1

Germano Geno J · CIK 0001424383 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 126,075

Underlying: Common Stock · 126,075 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such shares.

F2 · derivative.exercise_date: The RSUs vest on the earlier to occur of (i) May 4, 2024 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date.

F2 · derivative.expiration_date: The RSUs vest on the earlier to occur of (i) May 4, 2024 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date.

Read SEC document
May 04, 2023 Filed May 8, 2023 20:15 UTC GrantRestricted Stock Units · Derivative 126,075 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-027926 · doc4.xml · derivative · entry 1

Buehler Kevin · CIK 0001792722 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 126,075

Underlying: Common Stock · 126,075 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such shares.

F2 · derivative.exercise_date: The RSUs vest on the earlier to occur of (i) May 4, 2024 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date.

F2 · derivative.expiration_date: The RSUs vest on the earlier to occur of (i) May 4, 2024 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date.

Read SEC document
May 04, 2023 Filed May 8, 2023 20:15 UTC GrantRestricted Stock Units · Derivative 126,075 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-027928 · doc4.xml · derivative · entry 1

Wadsworth Samuel C. · CIK 0001653056 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 126,075

Underlying: Common Stock · 126,075 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such shares.

F2 · derivative.exercise_date: The RSUs vest on the earlier to occur of (i) May 4, 2024 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date.

F2 · derivative.expiration_date: The RSUs vest on the earlier to occur of (i) May 4, 2024 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date.

Read SEC document
May 04, 2023 Filed May 8, 2023 20:15 UTC GrantRestricted Stock Units · Derivative 126,075 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-027925 · doc4.xml · derivative · entry 1

Pire Shari Lisa · CIK 0001892150 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 126,075

Underlying: Common Stock · 126,075 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such shares.

F2 · derivative.exercise_date: The RSUs vest on the earlier to occur of (i) May 4, 2024 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date.

F2 · derivative.expiration_date: The RSUs vest on the earlier to occur of (i) May 4, 2024 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date.

Read SEC document
May 04, 2023 Filed May 8, 2023 20:15 UTC GrantRestricted Stock Units · Derivative 126,075 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-027924 · doc4.xml · derivative · entry 1

Brown Melinda · CIK 0001682988 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 126,075

Underlying: Common Stock · 126,075 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such shares.

F2 · derivative.exercise_date: The RSUs vest on the earlier to occur of (i) May 4, 2024 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date.

F2 · derivative.expiration_date: The RSUs vest on the earlier to occur of (i) May 4, 2024 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date.

Read SEC document
April 27, 2023 Filed Apr 28, 2023 20:53 UTC
List AlanChief Medical Officer
SaleCommon Stock 7,771 $0.79 $6,139.09
Disclosure

SEC source: 0001209191-23-026066 · doc4.xml · nonDerivative · entry 2

List Alan · CIK 0001858530 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 56,496

F3 · kind: The sales were effected pursuant to a Rule 10b5-1 plan. The transaction was a sell-to-cover, with shares sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs.

Read SEC document
April 26, 2023 Filed Apr 28, 2023 20:53 UTC
List AlanChief Medical Officer
Exercise / conversionRestricted Stock Units · Derivative 26,027 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-026066 · doc4.xml · derivative · entry 3

List Alan · CIK 0001858530 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 26,028

Underlying: Common Stock · 26,027 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.

F4 · derivative.exercise_date: On June 7, 2021 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on April 26, 2022, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

F4 · derivative.expiration_date: On June 7, 2021 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on April 26, 2022, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

Read SEC document
April 26, 2023 Filed Apr 28, 2023 20:53 UTC
List AlanChief Medical Officer
Exercise / conversionCommon Stock 26,027 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-026066 · doc4.xml · nonDerivative · entry 1

List Alan · CIK 0001858530 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 64,267

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents the partial vesting and settlement of Restricted Stock Units ("RSUs") on April 26, 2023.

F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.